Singular Genomics Systems' shares surged following Deerfield Management's increased acquisition proposal. The stock price rose 60% to $21.60, with Deerfield offering $24 per share. Negotiations are ongoing, with an exclusivity agreement in place, but the acquisition is not yet guaranteed.